← Back to Analyst Consensus 
KLRA Buy
Kailera Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 12
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 4, 2026 (9 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| May 12, 2026 | Leerink Partners | initiate | — → Outperform | — | 50% |
| May 12, 2026 | Jefferies | initiate | — → Buy | — | 52% |
| May 12, 2026 | Evercore ISI Group | initiate | — → Outperform | — | 58% |
| May 12, 2026 | JP Morgan | initiate | — → Overweight | — | 55% |
Price Target Trend
May 13, 2026 Latest: $42.75 Oct 25, 2026
EPS Estimates
0q $-1.01
Lo: $-1.30 Hi: $-0.79
5 analysts ▲1
+1q $-1.16
Lo: $-1.54 Hi: $-0.95
5 analysts ▲1
+1y $-4.30
Lo: $-5.89 Hi: $-2.99
5 analysts ▲1
0y $-4.10
Lo: $-5.86 Hi: $-2.96
5 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days